Ultrasound Guided Intra-uterine Device Insertion

August 30, 2015 updated by: Dina Mohamed Refaat Dakhly, Woman's Health University Hospital, Egypt

A Further Step Towards Painless Intrauterine Device Insertion, a Randomized Control Trial

Different studies have been made in an attempt to reduce the pain and the duration of the process of outpatient insertion of the intrauterine device. in this trial, the investigators aim to insert the IUD under ultrasonographic guidance, which can help to reduce the pain, decrease the process of insertion, in addition, it reduces the incidence of malposition of IUD as well as the risk of complications.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 12211
        • Kasr El Ainy hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Females desiring contraception with the use of IUD

Exclusion Criteria:

  • Are pregnant or think they may be pregnant
  • Septic pregnancy or abortion
  • Have unexplained abnormal vaginal bleeding
  • Have untreated cervical cancer
  • Have malignant gestational trophoblastic disease
  • Have uterine cancer
  • Have uterine abnormalities
  • Have or may have had a pelvic infection within the past three months
  • Have or may have any sexually transmitted disease
  • Have pelvic tuberculosis
  • Are postpartum between 48 hours and 4 weeks
  • Have benign gestational trophoblastic disease
  • Have ovarian cancer
  • Have AIDS (unless clinically well on anti-retroviral therapy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ultrasound guided group
the female will be asked to be full bladder. the trans-abdominal probe will be placed by an assistant on the suprapubic region. under speculum examination, the intrauterine device IUD (TCu 380A) will be placed till it reaches the fundus of the uterus and then released.
Other Names:
  • TCu 380A
Experimental: Non ultrasound guided group
the intrauterine device TCu 380A will be inserted in the conventional method, and checked afterwards by transvaginal ultrasound.
Other Names:
  • TCu 380A

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of degree of pain during IUD insertion
Time Frame: 6 months
Pain will be assessed by the use of visual analog scale, Pain rating scale
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

January 23, 2015

First Submitted That Met QC Criteria

March 18, 2015

First Posted (Estimate)

March 19, 2015

Study Record Updates

Last Update Posted (Estimate)

September 1, 2015

Last Update Submitted That Met QC Criteria

August 30, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 22012015

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Clinical Trials on intrauterine device TCu 380A

Subscribe